Cargando…

Nanoparticle-Mediated Drug Delivery System for Pulmonary Arterial Hypertension

Nanoparticles have been used as a novel drug delivery system. Drug-incorporated nanoparticles for local delivery might optimize the efficacy and minimize the side effects of drugs. The efficacy and safety of intratracheal administration of prostacyclin analog (beraprost) -incorporated nanoparticles...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakamura, Kazufumi, Matsubara, Hiromi, Akagi, Satoshi, Sarashina, Toshihiro, Ejiri, Kentaro, Kawakita, Norifumi, Yoshida, Masashi, Miyoshi, Toru, Watanabe, Atsuyuki, Nishii, Nobuhiro, Ito, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5447939/ https://www.ncbi.nlm.nih.gov/pubmed/28468233 http://dx.doi.org/10.3390/jcm6050048

Ejemplares similares

Suppression of Wnt Signaling and Osteogenic Changes in Vascular Smooth Muscle Cells by Eicosapentaenoic Acid
por: Saito, Yukihiro, et al.
Publicado: (2017)

Epoprostenol sodium for treatment of pulmonary arterial hypertension
por: Saito, Yukihiro, et al.
Publicado: (2015)

Current Treatment Strategies and Nanoparticle-Mediated Drug Delivery Systems for Pulmonary Arterial Hypertension
por: Nakamura, Kazufumi, et al.
Publicado: (2019)

Crucial role of RAGE in inappropriate increase of smooth muscle cells from patients with pulmonary arterial hypertension
por: Nakamura, Kazufumi, et al.
Publicado: (2018)

Treat-and-repair strategy is a feasible therapeutic choice in adult patients with severe pulmonary arterial hypertension associated with a ventricular septal defect: case series
por: Akagi, Satoshi, et al.
Publicado: (2018)

Impact of malnutrition on prognosis in patients with pulmonary arterial hypertension
por: Nakashima, Mitsutaka, et al.
Publicado: (2023)

Improvement of lung function and pulmonary hypertension after pulmonary aneurysm repair: case series
por: Akagi, Satoshi, et al.
Publicado: (2019)

Quantification of Lung Perfusion Blood Volume in Dual-Energy Computed Tomography in Patients with Pulmonary Hypertension
por: Ugawa, Satoko, et al.
Publicado: (2022)

Protective effect of nicorandil on myocardial injury following percutaneous coronary intervention in older patients with stable coronary artery disease: Secondary analysis of a randomized, controlled trial (RINC)
por: Kawakita, Norifumi, et al.
Publicado: (2018)

Liver transplantation in a patient with hereditary haemorrhagic telangiectasia and pulmonary hypertension
por: Ejiri, Kentaro, et al.
Publicado: (2019)

Successful radiofrequency catheter ablation of a premature ventricular contraction triggering ventricular fibrillation in a patient with short QT syndrome
por: Morimoto, Yoshimasa, et al.
Publicado: (2019)

Microcalcification and (99m)Tc-Pyrophosphate Uptake without Increased Bone Metabolism in Cardiac Tissue from Patients with Transthyretin Cardiac Amyloidosis
por: Mori, Atsushi, et al.
Publicado: (2023)

Pathophysiology and Treatment of Diabetic Cardiomyopathy and Heart Failure in Patients with Diabetes Mellitus
por: Nakamura, Kazufumi, et al.
Publicado: (2022)

Evidence for Hypoxia-Induced Shift in ATP Production from Glycolysis to Mitochondrial Respiration in Pulmonary Artery Smooth Muscle Cells in Pulmonary Arterial Hypertension
por: Akagi, Satoshi, et al.
Publicado: (2023)

Initial experience with the subcutaneous implantable cardioverter-defibrillator in a single Japanese center
por: Nishii, Nobuhiro, et al.
Publicado: (2017)

A Low Critical Event Rate Despite a High Abnormal Event Rate in Patients with Cardiac Implantable Electric Devices Followed Up by Remote Monitoring
por: Morimoto, Yoshimasa, et al.
Publicado: (2019)

Enhancement of pacing function by HCN4 overexpression in human pluripotent stem cell-derived cardiomyocytes
por: Saito, Yukihiro, et al.
Publicado: (2022)

Epicardially placed implantable cardioverter-defibrillator for a child with congenital long QT syndrome
por: Sugiyama, Hirotaro, et al.
Publicado: (2017)

Effect of Luseogliflozin on Heart Failure With Preserved Ejection Fraction in Patients With Diabetes Mellitus
por: Ejiri, Kentaro, et al.
Publicado: (2020)

Effects of luseogliflozin and voglibose on high-risk lipid profiles and inflammatory markers in diabetes patients with heart failure
por: Ejiri, Kentaro, et al.
Publicado: (2022)

Combination of Renal Angioplasty and Angiotensin-converting-enzyme Inhibitor Can Reduce Proteinuria in Patients with Bilateral Renal Artery Disease
por: Toda, Hironobu, et al.
Publicado: (2019)

Prognostic value of non-alcoholic fatty liver disease for predicting cardiovascular events in patients with diabetes mellitus with suspected coronary artery disease: a prospective cohort study
por: Ichikawa, Keishi, et al.
Publicado: (2021)

Intratracheal Administration of Prostacyclin Analogue–incorporated Nanoparticles Ameliorates the Development of Monocrotaline and Sugen-Hypoxia-induced Pulmonary Arterial Hypertension
por: Akagi, Satoshi, et al.
Publicado: (2016)

Effect of LCZ696, a dual angiotensin receptor neprilysin inhibitor, on isoproterenol-induced cardiac hypertrophy, fibrosis, and hemodynamic change in rats
por: Miyoshi, Toru, et al.
Publicado: (2019)

Pemafibrate Prevents Rupture of Angiotensin II-Induced Abdominal Aortic Aneurysms
por: Amioka, Naofumi, et al.
Publicado: (2022)

Prevalence and Treatment of Arrhythmias in Patients With Transthyretin and Light-Chain Cardiac Amyloidosis
por: Miyamoto, Masakazu, et al.
Publicado: (2023)

Effects of luseogliflozin on estimated plasma volume in patients with heart failure with preserved ejection fraction
por: Nakashima, Mitsutaka, et al.
Publicado: (2021)

LCZ696 ameliorates doxorubicin-induced cardiomyocyte toxicity in rats
por: Miyoshi, Toru, et al.
Publicado: (2022)

Efficacy of shear wave elasticity for evaluating myocardial hypertrophy in hypertensive rats
por: Takaya, Yoichi, et al.
Publicado: (2021)

The effect of luseogliflozin and alpha-glucosidase inhibitor on heart failure with preserved ejection fraction in diabetic patients: rationale and design of the MUSCAT-HF randomised controlled trial
por: Ejiri, Kentaro, et al.
Publicado: (2019)

Deficiency of CD44 prevents thoracic aortic dissection in a murine model
por: Hatipoglu, Omer F., et al.
Publicado: (2020)

Beta-Blockers and Oxidative Stress in Patients with Heart Failure
por: Nakamura, Kazufumi, et al.
Publicado: (2011)

Prognosis after lead extraction in patients with cardiac implantable electronic devices infection: Comparison of lead‐related infective endocarditis with pocket infection in a Japanese single‐center experience
por: Nishii, Nobuhiro, et al.
Publicado: (2019)

Significant Delayed Activation on the Right Ventricular Outflow Tract Represents Complete Right Bundle‐Branch Block Pattern in Brugada Syndrome
por: Morimoto, Yoshimasa, et al.
Publicado: (2023)

Circulating KCNH2 Current-Activating Factor in Patients with Heart Failure and Ventricular Tachyarrhythmia
por: Sugiyama, Hiroki, et al.
Publicado: (2011)

Effect of vildagliptin, a dipeptidyl peptidase 4 inhibitor, on cardiac hypertrophy induced by chronic beta-adrenergic stimulation in rats
por: Miyoshi, Toru, et al.
Publicado: (2014)

In vivo tracking transplanted cardiomyocytes derived from human induced pluripotent stem cells using nuclear medicine imaging
por: Saito, Yukihiro, et al.
Publicado: (2023)

Myocardial Late Iodine Enhancement Using Photon-Counting Computed Tomography in Patients With Hypertrophic Cardiomyopathy
por: Nishihara, Takahiro, et al.
Publicado: (2023)

Tobacco smoking protective effect via remote ischemic preconditioning on myocardial damage after elective percutaneous coronary intervention: Subanalysis of a randomized controlled trial
por: Ejiri, Kentaro, et al.
Publicado: (2018)

Treatment of Vascular Injury During Balloon Pulmonary Angioplasty in Patients With Chronic Thromboembolic Pulmonary Hypertension
por: Ejiri, Kentaro, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rc8uokshphi156bub3l2eougso